Tugba Basoglu Tuylu

19PUBLICATIONS
88CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunityMolecular targetsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 15, 2026
Real-World Treatment Outcomes After Nivolumab Progression in BRAF-Negative Metastatic Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group.

|Jun 26, 2026
Prognostic Significance of Preoperative PET-CT SUVmax in Resected Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

|Jan 28, 2026
Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study.

Ugur Ozkerim, Oguzcan Kinikoglu, Sila Oksuz

|Jan 27, 2026
Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study.

Ugur Ozkerim, Deniz Isik, Oguzcan Kinikoglu

|Jan 10, 2026
Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide.

Ugur Ozkerim, Oguzcan Kinikoglu, Deniz Isik

|Nov 26, 2025
Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study.

İlknur Deliktaş Onur, Mutlu Doğan, Mehmet Akif Öztürk

Pageof 4

Frequent Collaborators

9 joint publications

Deniz Işık

9 joint publications

Hatice Odabas

9 joint publications

Nedim Turan

8 joint publications

Oguzcan Kınıkoğlu